TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
65 hedge funds and large institutions have $244M invested in Trillium Therapeutics Inc. in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
Holders
65
Holding in Top 10
2
Calls
$2.08M
Puts
$836K
Top Buyers
| 1 | +$25.7M | |
| 2 | +$20M | |
| 3 | +$16.5M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$14.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.9M |
Top Sellers
| 1 | -$9.43M | |
| 2 | -$6.8M | |
| 3 | -$1.13M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$342K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$50.6K |